Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy

Published:2024 Issue: Volume: Page:
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Xu Xiangrui¹^ORCID,Zhang Yaowen¹,Meng Chijun¹,Zheng Wenzhuo¹,Wang Lingfeng¹,Zhao Chenyi¹,Luo Feng²^ORCID

Affiliation:

1. State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China

2. Department of Prosthodontics, West China School of Stomatology, Sichuan University, No. 14, Section 3, Renmin Nanlu, Chengdu 610041, China

Abstract

The unique roles of nanozymes in enhancing immunotherapy through disrupting tumor metabolism and mediating combination therapies.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D4TB00769G

Reference300 articles.

1. Biomaterial-assisted targeted modulation of immune cells in cancer treatment

2. Combination strategies to maximize the benefits of cancer immunotherapy

3. A guide to cancer immunotherapy: from T cell basic science to clinical practice

4. Cold Tumors: A Therapeutic Challenge for Immunotherapy

5. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP